Kerry Reynolds
@kerryreynoldsmd.bsky.social
Oncologist & Clinical Researcher @MassGeneralCancerCenter | Director, Severe Immunotherapy Complications (SIC) Service | Focused on immune-related adverse events (irAEs), advancing care, research, and cross-disciplinary collaboration #ASPIRE #irAE #ASCO25
Reposted by Kerry Reynolds
🎉 Excited to launch the @ascocancer.bsky.social #ASPIRE Community of Practice! Mark your #ASCO25 calendars: May 30, 4-6pm CST E253cd. Unite to improve the lives of people with #cancer and #irAE @funchainmd.bsky.social @kerryreynoldsmd.bsky.social @oncodaily.bsky.social
www.asco.org/annual-meeti...
www.asco.org/annual-meeti...
Communities of Practice - ASCO
www.asco.org
May 13, 2025 at 1:54 PM
🎉 Excited to launch the @ascocancer.bsky.social #ASPIRE Community of Practice! Mark your #ASCO25 calendars: May 30, 4-6pm CST E253cd. Unite to improve the lives of people with #cancer and #irAE @funchainmd.bsky.social @kerryreynoldsmd.bsky.social @oncodaily.bsky.social
www.asco.org/annual-meeti...
www.asco.org/annual-meeti...
First post— woo hoo! Join #ASPIRE, the global community advancing clinical care, education, and research in immune-related adverse events (#irAEs). Be part of our 300+ member network dedicated to making a difference! #ASCO25 @funchainmd.bsky.social @ascocaner.bsky.social @oncodaily.bsky.social
May 14, 2025 at 12:35 PM
First post— woo hoo! Join #ASPIRE, the global community advancing clinical care, education, and research in immune-related adverse events (#irAEs). Be part of our 300+ member network dedicated to making a difference! #ASCO25 @funchainmd.bsky.social @ascocaner.bsky.social @oncodaily.bsky.social